SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Steroids Aid Recovery From Pneumonia, UT Southwestern Medical Center Researchers Say
October 20, 2008
 · 
1 min read
Lone Star Bio
Brazilian Acai Berry Antioxidants Absorbed By Human Body, University of Texas Research Shows
October 17, 2008
 · 
1 min read
Lone Star Bio
Scientists Use Light To Control Proteins, Penn State University And University of Texas Southwestern Medical Center Study
October 17, 2008
 · 
1 min read
Drug Development
Merck & Co., Inc.'s Vioxx Heart Risk Persists One Year After Stopping Use, University of Texas MD Anderson Cancer Center Study
October 14, 2008
 · 
1 min read
Drug Development
Chemo Alone Effective in Treating Kids’ Brain Tumors, University of Texas MD Anderson Cancer Center Study
October 13, 2008
 · 
1 min read
Lone Star Bio
Artificial Heart Technology Holds Promise For Alternatives, Texas Heart Institute And University of Houston Report
October 10, 2008
 · 
1 min read
Lone Star Bio
RNA Molecules, Delivery System Improve Vaccine Responses, Effectiveness, University of Texas Study
October 9, 2008
 · 
1 min read
Policy
Federal Preemption Part 2: Medical Devices As A Case Study
October 8, 2008
 · 
1 min read
Lone Star Bio
Tamoxifen Chemoprevention Tied To Early Detection Of Breast Cancer, University of Texas MD Anderson Cancer Center Study
October 8, 2008
 · 
1 min read
Lone Star Bio
Robotic Surgery Lowers Risk Of A Rare But Serious Complication Of Gastric Bypass, University of Texas Medical School Study Suggests
September 30, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Load More